Robert J. Spiegel Insider Trading $EDGE PDS Biotechnology Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert J. Spiegel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert J. Spiegel. Robert J. Spiegel is Director in Capstone Therapeutics Corp. ($CAPS) and Director in GERON CORP ($GERN) and Director in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Chief Medical Officer in PTC THERAPEUTICS, INC. ($PTCT) and Director in Athenex, Inc. ($ATNX) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in Edge Therapeutics, Inc. ($EDGE).
Robert J. Spiegel in PDS Biotechnology Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Spiegel: Director
Holdings: 48,661 shares
Current Value: $464,713
Latest Transaction: Mar 18 2019
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robert J. Spiegel in PDS Biotechnology Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATNX, CAPS, CYCC, GERN, EDGE, PTCT, SCMP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Buy | M | 0.00 | 10,000 | 0 | 48,661 | 38.7 K to 48.7 K (+25.87 %) |
| Aug 15 2018 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jun 20 2018 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Option Exercise | A | 1.10 | 20,000 | 22,000 | 20,000 | |
| Jun 21 2017 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Option Exercise | A | 10.15 | 15,000 | 152,250 | 15,000 | |
| Jun 23 2016 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Option Exercise | A | 9.34 | 15,000 | 140,100 | 15,000 | |
| Jun 23 2016 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Option Exercise | A | 9.34 | 15,000 | 140,100 | 15,000 | |
| Oct 08 2015 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Option Exercise | C | 0.00 | 14,409 | 0 | 0 | |
| Oct 08 2015 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Option Exercise | C | 0.00 | 32,258 | 0 | 0 | |
| Oct 08 2015 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Buy | J | 7.91 | 1,549 | 12,253 | 38,661 | 37.1 K to 38.7 K (+4.17 %) |
| Oct 08 2015 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Buy | P | 11.00 | 3,000 | 33,000 | 37,112 | 34.1 K to 37.1 K (+8.79 %) |
| Oct 08 2015 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Buy | C | 0.00 | 10,533 | 0 | 34,112 | 23.6 K to 34.1 K (+44.67 %) |
| Oct 08 2015 | EDGE | Edge Therapeutics, ... | Spiegel Robert J. | Director | Buy | C | 0.00 | 23,579 | 0 | 23,579 | 0 to 23.6 K |
Page: 1